X0306 4 2020-02-25 1 0001169987 HTG MOLECULAR DIAGNOSTICS, INC HTGM 0001105806 LYTTON LAURENCE W 467 CENTRAL PARK WEST NEW YORK NY 10025 0 0 1 0 Common Stock 2020-02-25 4 J 0 4110000 0 D 2297173 D Series A Convertible Preferred Stock 0 2020-02-25 4 J 0 1167 0 A Common Stock 116700 1167 D Series A Convertible Preferred Stock 0 2020-02-25 4 P 0 193 59 A Common Stock 19300 193 I Lytton Kambara Foundation Series A Convertible Preferred Stock 0 2020-02-25 4 P 0 96 59 A Common Stock 9600 96 I AWL Family LLC Surrendered to the Issuer in exchange for shares of the Issuer's newly designated Series A Convertible Preferred Stock, par value $0.001 per share ("Series A Preferred"). Each share of Series A Preferred is convertible into 100 shares of the Issuer's common stock at the holder's election, subject to beneficial ownership limitations, and has no expiration date. Issued in exchange for the surrender of shares of the Issuer's Common Stock. As discussed above, the exercise of the Series A Preferred is subject to beneficial ownership limitations. The number of shares shown is the number not subject to such limitations. Lytton Kambara Foundation is a non-profit entity for which Mr. Lytton has investment discretion. Mr. Lytton has no pecuniary interest in and disclaims beneficial ownership of these securities and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Mr. Lytton has no pecuniary interest in and disclaims any beneficial ownership of these securities and this report shall not be deemed an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. Laurence W. Lytton 2020-02-27